Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-046569
Filing Date
2011-08-12
Accepted
2011-08-12 16:06:03
Documents
12
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-18731_110q.htm 10-Q 954036
2 EX-10.2 a11-18731_1ex10d2.htm EX-10.2 6155
3 EX-31.1 a11-18731_1ex31d1.htm EX-31.1 9553
4 EX-31.2 a11-18731_1ex31d2.htm EX-31.2 10516
5 EX-32.1 a11-18731_1ex32d1.htm EX-32.1 5705
6 EX-32.2 a11-18731_1ex32d2.htm EX-32.2 5523
  Complete submission text file 0001104659-11-046569.txt   3402196

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT anth-20110630.xml EX-101.INS 470134
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anth-20110630.xsd EX-101.SCH 13800
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anth-20110630_cal.xml EX-101.CAL 33174
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT anth-20110630_lab.xml EX-101.LAB 218149
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anth-20110630_pre.xml EX-101.PRE 101004
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anth-20110630_def.xml EX-101.DEF 63507
Mailing Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545
Business Address 25801 INDUSTRIAL BOULEVARD, SUITE B HAYWARD CA 94545 (510) 856-5600
Anthera Pharmaceuticals Inc (Filer) CIK: 0001316175 (see all company filings)

EIN.: 201852016 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34637 | Film No.: 111031431
SIC: 2834 Pharmaceutical Preparations